文献速递临床试验与 GCP流行病学与生物统计

Hans Kai试验:评估面向非传染性疾病患者及健康成人的同伴主导健康促进项目的混合方法随机对照试验研究方案

The Hans Kai trial: study protocol of a mixed methods randomized controlled trial evaluating a peer-led health promotion program for adults with or without noncommunicable diseases.
PubMed 文献 · Trials · 2023-10-24

该方案描述一项混合方法随机对照试验,将105名成人随机分为Hans Kai干预组(n=70)和标准照护对照组(n=35),进行6个月2组平行优效性随机对照试验,随后开展12-18个月观察性随访,并定性研究参与者(n=30)和引导者(n=15)的体验。

要点

  • Hans Kai为医护人员授课后由同伴定期主持自治小组会议的健康促进项目。
  • 随机对照试验纳入105名成人,干预组70人、对照组35人,不设盲。
  • 随机对照试验后设12-18个月观察性随访以评估6个月结局的长期持续性。

核心结论

  • 随机对照试验结果将有助于支持Hans Kai及其他同伴主导健康促进干预的进一步开发和使用。

研究设计与样本

  • 混合方法试验,包括6个月2组平行优效性随机对照试验,105名成人随机分为Hans Kai干预组(n=70)和标准照护对照组(n=35),使用计算机生成随机序列,不设盲。
  • 随机对照试验后开展12-18个月观察性随访研究,提供6个月随机对照试验健康结局长期持久性的数据。
  • 定性部分调查项目参与者(n=30)和引导者(n=15)的体验。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: A significant proportion of Canadian adults is impacted by chronic noncommunicable diseases. These conditions may be improved by peer-led health promotion interventions that target modifiable risk factors; however, to date, there is mixed evidence on the effectiveness of these interventions. Unlike other health promotion programs, Hans Kai is grounded in a holistic model of health that simultaneously addresses multiple determinants of health at different levels of human ecology. In Hans Kai, a set of informational sessions that are delivered in a group setting by healthcare professionals are followed by regular peer-led group meetings in a self-governed support group setting that is designed to promote implementation of newly learned health competences. The Hans Kai trial described here aims to evaluate the efficacy of the Hans Kai program in promoting the health and wellbeing of its participants and investigate the experiences of the Hans Kai participants and facilitators. METHODS: This research will involve a mixed methods trial combining an experimental component with a qualitative component. The experimental component will involve a 6-month 2-group parallel superiority randomized controlled trial (RCT) in which 105 participants will be randomly assigned to two conditions, an intervention group (n = 70) that will participate in the Hans Kai program and a control group (n = 35) that will have access to standard care using a computer-generated random sequence; blinding will not occur. The RCT will test the impact of the program on several health outcomes and will be followed by a 12-18-month observational follow-up study that will provide data on the long-term durability of the 6-month RCT health outcomes. The qualitative component will investigate the experiences of program participants (n = 30) and facilitators (n = 15) to identify the main strengths and limitations of Hans Kai, uncover potential implementation issues, and elucidate the mechanisms through which the program works. The population of interest will include adults aged 18 + with or without chronic health conditions who self-report an interest in taking control of their own health and improving their lifestyle. In the RCT, all outcomes of interest will be measured using a multi-method approach, involving self-report questionnaires and objective indicators, and within-subject mean changes in outcomes over time between the two groups will be compared to address the RCT aims. Similarly, in the qualitative component, a multi-method approach, involving in-depth individual interviews, photovoice, and online surveys, will be used to reach a deeper and more nuanced understanding of the program strengths, how the program works, and for which people it is more effective. Adaptable components of the program will also be investigated and modified according to the feedback provided by the RCT participants. In the mixed methods integration of evidence, the qualitative findings will be used to explain the quantitative RCT results. DISCUSSION: The RCT findings will help support the further development and use of Hans Kai as well as other peer-led health promotion interventions. TRIAL REGISTRATION: United Stated Clinical Trial Registry ClinicalTrials.gov (registration# NCT03949725; Protocol version 2, June 22nd, 2022).

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Cameranesi M, Mollard R, Balshaw R, et al. The Hans Kai trial: study protocol of a mixed methods randomized controlled trial evaluating a peer-led health promotion program for adults with or without noncommunicable diseases. Trials. 2023. PMID: 37875962. doi:10.1186/s13063-023-07708-z

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。